Ying-Hao Shen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Minimally Invasive

Transcription Factor

Top Venues

Journal of hepatocellular carcinoma

Surgical innovation

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pei Wang, Ming-Hao Xu, Wen-Xin Xu, Zi-Ying Dong, Ying-Hao Shen, Wen-Zheng Qin
CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils. Journal of hepatocellular carcinoma 11 (2024)
Pei Wang, Ming-Hao Xu, Wen-Xin Xu, Zi-Ying Dong, Ying-Hao Shen, Wen-Zheng Qin
CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils. Journal of hepatocellular carcinoma 11 (2024)
Ming-Hao Xu, Cheng Huang, Mei-Ling Li, Xiao-Dong Zhu, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun, Ying-Hao Shen
Effectiveness and safety of lenvatinib plus anti-programmed death-1 antibodies in patients with hepatocellular carcinoma: A real-world cohort study. Cancer medicine (2023)
Nan Xiao, Xiao-Long Li, Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun
Increase of Portal Vein Pressure Gradient After Hepatectomy Predicts Post-operative Liver Dysfunction. Surgical innovation (2021)